Small Molecule Inhibitor of Antigen Binding and Presentation by HLA-DR2b as a Therapeutic Strategy for the Treatment of Multiple Sclerosis
2013 ◽
Vol 191
(10)
◽
pp. 5074-5084
◽
Keyword(s):